Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biotricity Inc
(NQ:
BTCY
)
0.9800
-0.1000 (-9.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biotricity Inc
< Previous
1
2
3
4
Next >
Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications
July 25, 2023
Via
ACCESSWIRE
Biotricity Regains Nasdaq Listing Compliance
July 21, 2023
Via
ACCESSWIRE
Biotricity Reports Strong Start to Fiscal Year 2024
July 06, 2023
Via
ACCESSWIRE
Biotricity Announces Reverse Stock Split
June 30, 2023
Via
ACCESSWIRE
Biotricity Reports Business Update, Financial Results for Q4 and Full Year FY23; Company Posts Robust Revenue Growth, Overall Higher Margins, with Lower SG&A Driving Clear Path to Positive Cash Flow
June 30, 2023
Via
ACCESSWIRE
Biotricity to Host Fiscal Year 2023 Financial Results and Business Update Call on June 30th
June 26, 2023
Via
ACCESSWIRE
Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare
May 23, 2023
Via
ACCESSWIRE
Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth
May 16, 2023
Via
ACCESSWIRE
Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
May 10, 2023
Via
ACCESSWIRE
New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products
April 21, 2023
Via
ACCESSWIRE
Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth Ahead
April 19, 2023
Via
ACCESSWIRE
Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report
April 11, 2023
Via
ACCESSWIRE
Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation
March 07, 2023
Via
ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 Third Quarter
February 14, 2023
Via
ACCESSWIRE
Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET
February 09, 2023
Via
ACCESSWIRE
Biotricity Surpasses $10 Million in Annual Revenue Run Rate
November 21, 2022
Via
ACCESSWIRE
Biotricity Provides Updates on its Operational and Expansion Strategy
November 18, 2022
Via
ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 Second Quarter
November 14, 2022
Via
ACCESSWIRE
Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022
November 10, 2022
Via
ACCESSWIRE
Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
February 03, 2023
Via
ACCESSWIRE
Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions
January 26, 2023
Via
ACCESSWIRE
Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
January 23, 2023
Via
ACCESSWIRE
Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023
January 17, 2023
Via
ACCESSWIRE
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
December 12, 2022
Via
ACCESSWIRE
Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib)
October 04, 2022
Via
ACCESSWIRE
Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions
November 16, 2022
Via
ACCESSWIRE
Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET
November 01, 2022
Via
ACCESSWIRE
Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics
October 26, 2022
Via
ACCESSWIRE
Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th
October 13, 2022
Via
ACCESSWIRE
Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure
September 07, 2022
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.